Clinical Guidelines

Parkinson’s is a complex neurodegenerative disease that is characterized by slowness of movement, rigidity, tremor and postural instability.

Neuropsychiatric symptoms are also prevalent, sometimes prior to the motor symptoms, and include depression, dementia and psychosis. Symptoms can vary substantially from patient to patient.

The aim of the Canadian Guidelines on Parkinson’s disease is to enhance the care for all Canadians with Parkinson’s.
These Guidelines
  • are based on the best published evidence
  • involve expert consensus when there is lack of evidence
  • offer practical clinical advice
  • take into account patient choice and informed decision making
  • are relevant to the Canadian health care system.

To get started, explore the full Clinical Guidelines (PDF), the Executive Summary (PDF), or the Introduction to Clinical Guidelines (PPT) or click on one of the buttons below.
If you have a question or comment related to these materials please contact us

Printing of this material is limited to copies for individual use. Reproduction is prohibited without prior permission from Parkinson Canada. Should you require more copies, contact us.

The Canadian Guidelines on Parkinson’s Disease are a consensus of previously published Guidelines from other countries.
Resources supporting the Canadian Guidelines:

American Academy of Neurology (PDF)
European Federation of Neurological Societies (PDF)
National Institute for Health and Clinical Excellence United Kingdom (PDF)